An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study

This prospective, multicenter, single‐arm, open‐label phase 3 study aimed to evaluate the efficacy and safety of IqYmune in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Patients received one induction dose of 2 g/kg and then seven maintenance doses of 1 g/kg at 3‐w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobile‐Orazio, Eduardo, Pujol, Sonia, Kasiborski, Fabrice, Ouaja, Rabye, Corte, Gilles Della, Bonek, Robert, Cocito, Dario, Schenone, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754365/
https://www.ncbi.nlm.nih.gov/pubmed/32808406
http://dx.doi.org/10.1111/jns.12408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754365/
https://www.ncbi.nlm.nih.gov/pubmed/32808406
http://dx.doi.org/10.1111/jns.12408

Ejemplares similares